Back to Results
First PageMeta Content
Johnson & Johnson / LifeScan


Universal Biosensors Ltd UBI.ASX Q3 CY2012 boosted by Blood Glucose growth The strong Q3 and YTD Operating Profit of $1.9m and $4.7m was supported by
Add to Reading List

Document Date: 2012-11-06 17:16:06


Open Document

File Size: 435,01 KB

Share Result on Facebook

Company

Change Working Capital / Veritas Securities Ltd / Meters 6 Veritas Securities Ltd / Total MarketROW Launch / LifeScan / Universal Biosensors Ltd / Siemens / /

Continent

North America / Europe / /

Country

Australia / United States / /

Currency

AUD / USD / /

Event

Earnings Guidance / Business Partnership / /

Facility

Development Pipeline / /

IndustryTerm

test systems / blood coagulation products / blood diagnostic product / /

MarketIndex

S&P/ASX Small Industrial / /

Organization

European Union / /

Technology

Verio technology / diagnostic tests / /

SocialTag